Brokerage firm Bank of America Reinstates its rating on Owens & Minor(NYSE:OMI). The shares have been rated Neutral. The rating by Bank of America was issued on Sep 12, 2016.
Owens & Minor (OMI) shares turned negative on Tuesdays trading session with the shares closing down -0.08 points or -0.24% at a volume of 3,46,349. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $34.04. The peak price level was also seen at $34.04 while the days lowest was $33.64. Finally the shares closed at $33.64. The 52-week high of the shares is $41.48 while the 52-week low is $31.89. According to the latest information available, the market cap of the company is $2,099 M.
Owens & Minor(OMI) last announced its earnings results on Aug 2, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $2.48B. Analysts had an estimated revenue of $2.47B. Earnings per share were $0.52. Analysts had estimated an EPS of $0.49.
Several Insider Transactions has been reported to the SEC. On Sep 1, 2016, Erika T Davis (SVP, Chief of Staff) sold 2,900 shares at $34.31 per share price.Also, On Aug 8, 2016, Craig R Smith (director) sold 7,500 shares at $35.42 per share price.On Feb 24, 2016, Richard W Mears (SVP, Chief Information Officer) sold 6,000 shares at $39.11 per share price, according to the Form-4 filing with the securities and exchange commission.
Owens & Minor Inc. is a healthcare logistics company. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products supplies and devices. The Company operates in two segments: Domestic and International. Domestic segment includes all functions in the United States relating to its role as a healthcare logistics company providing distribution packaging and logistics services to healthcare providers and manufacturers. International segment consists of its European third-party logistics and packaging businesses. It is focused on its operations on healthcare logistics services and provides its customers with a service portfolio that covers procurement inventory management delivery and sourcing of products for the healthcare market. Its customers include hospitals integrated healthcare systems group purchasing organizations manufacturers of life-science and medical devices and supplies including pharmaceuticals.